215 related articles for article (PubMed ID: 10591476)
1. The effects of a newly synthesized ATP-sensitive potassium channel opener, MJ-355, on blood pressure and myocardial ischemia-reperfusion injury in rats.
Lee YM; Peng YY; Sheu JR; Cheng CY; Yen MH
Jpn J Pharmacol; 1999 Oct; 81(2):185-93. PubMed ID: 10591476
[TBL] [Abstract][Full Text] [Related]
2. The antihypertensive and cardioprotective effects of (-)-MJ-451, an ATP-sensitive K(+) channel opener.
Lee YM; Yen MH; Peng YY; Sheu JR; Chen YC; Chang MJ; Cheng CY
Eur J Pharmacol; 2000 May; 397(1):151-60. PubMed ID: 10844109
[TBL] [Abstract][Full Text] [Related]
3. Is the sarcolemmal or mitochondrial K(ATP) channel activation important in the antiarrhythmic and cardioprotective effects during acute ischemia/reperfusion in the intact anesthetized rabbit model?
Das B; Sarkar C
Life Sci; 2005 Jul; 77(11):1226-48. PubMed ID: 15964023
[TBL] [Abstract][Full Text] [Related]
4. Adenosine triphosphate-sensitive potassium channel blocking agent ameliorates, but the opening agent aggravates, ischemia/reperfusion-induced injury. Heart function studies in nonfibrillating isolated hearts.
Tosaki A; Hellegouarch A
J Am Coll Cardiol; 1994 Feb; 23(2):487-96. PubMed ID: 8294705
[TBL] [Abstract][Full Text] [Related]
5. Mitochondrial K ATP channel activation is important in the antiarrhythmic and cardioprotective effects of non-hypotensive doses of nicorandil and cromakalim during ischemia/reperfusion: a study in an intact anesthetized rabbit model.
Das B; Sarkar C
Pharmacol Res; 2003 Jun; 47(6):447-61. PubMed ID: 12741997
[TBL] [Abstract][Full Text] [Related]
6. KR-31762, a novel KATP channel opener, exerts cardioprotective effects by opening SarcKATP channels in rat models of ischemia/reperfusion-induced heart injury.
Lee SH; Yang MK; Lim JH; Seo HW; Yi KY; Yoo SE; Lee BH; Won HS; Lee CS; Choi WS; Shin HS
Arch Pharm Res; 2008 Apr; 31(4):482-9. PubMed ID: 18449506
[TBL] [Abstract][Full Text] [Related]
7. Potassium channel openers and blockers: do they possess proarrhythmic or antiarrhythmic activity in ischemic and reperfused rat hearts?
Tosaki A; Szerdahelyi P; Engelman RM; Das DK
J Pharmacol Exp Ther; 1993 Dec; 267(3):1355-62. PubMed ID: 8263798
[TBL] [Abstract][Full Text] [Related]
8. Cardioprotective effects of KR-30450, a novel K+(ATP) opener, and its major metabolite KR-30818 on isolated rat hearts.
Jung YS; Moon CH; Cho TS; Yoo SE; Shin HS
Jpn J Pharmacol; 1998 Jan; 76(1):65-73. PubMed ID: 9517406
[TBL] [Abstract][Full Text] [Related]
9. KATP channel modulators increase survival rate during coronary occlusion-reperfusion in anaesthetized rats.
Baczkó I; Leprán I; Papp JG
Eur J Pharmacol; 1997 Apr; 324(1):77-83. PubMed ID: 9137916
[TBL] [Abstract][Full Text] [Related]
10. ATP-sensitive potassium-channel-opening activity of CL-065, a 3-[(substituted-carbonyl)amino]-2H-1-benzopyran, in the rat.
Chen MJ; Lee YM; Sheu JR; Hu CT; Yen MH
J Pharm Pharmacol; 1998 Jan; 50(1):83-90. PubMed ID: 9504439
[TBL] [Abstract][Full Text] [Related]
11. A K(ATP) channel opener inhibited myocardial reperfusion action potential shortening and arrhythmias.
Workman AJ; MacKenzie I; Northover BJ
Eur J Pharmacol; 2001 May; 419(1):73-83. PubMed ID: 11348633
[TBL] [Abstract][Full Text] [Related]
12. Selective mitochondrial KATP channel activation by nicorandil and 3-pyridyl pinacidil results in antiarrhythmic effect in an anesthetized rabbit model of myocardial ischemia/reperfusion.
Das B; Sarkar C
Methods Find Exp Clin Pharmacol; 2003 Mar; 25(2):97-110. PubMed ID: 12731455
[TBL] [Abstract][Full Text] [Related]
13. Diabetes and ATP-sensitive potassium channel openers and blockers in isolated ischemic/reperfused hearts.
Tosaki A; Engelman DT; Engelman RM; Das DK
J Pharmacol Exp Ther; 1995 Dec; 275(3):1115-23. PubMed ID: 8531071
[TBL] [Abstract][Full Text] [Related]
14. Selective mitochondrial K(ATP) channel activation results in antiarrhythmic effect during experimental myocardial ischemia/reperfusion in anesthetized rabbits.
Das B; Sarkar C; Karanth KS
Eur J Pharmacol; 2002 Feb; 437(3):165-71. PubMed ID: 11890905
[TBL] [Abstract][Full Text] [Related]
15. Attenuation of KATP channel-opener induced shortening of repolarization time by alpha 1-adrenoceptor antagonist during ischemia in canine heart.
Tanabe T; Aikawa M; Deguchi Y; Yoshioka K; Handa S
Cardiovasc Drugs Ther; 2000 Jun; 14(3):283-94. PubMed ID: 10935150
[TBL] [Abstract][Full Text] [Related]
16. Hemodynamic profile of SKP-450, a new potassium-channel activator.
Lee BH; Yoo SE; Shin HS
J Cardiovasc Pharmacol; 1998 Jan; 31(1):85-94. PubMed ID: 9456282
[TBL] [Abstract][Full Text] [Related]
17. Cardioprotective profile of the cardiac-selective ATP-sensitive potassium channel opener BMS-180448.
Grover GJ; McCullough JR; D'Alonzo AJ; Sargent CA; Atwal KS
J Cardiovasc Pharmacol; 1995 Jan; 25(1):40-50. PubMed ID: 7723352
[TBL] [Abstract][Full Text] [Related]
18. KATP channel modulation in working rat hearts with coronary occlusion: effects of cromakalim, cicletanine, and glibenclamide.
Ferdinandy P; Szilvássy Z; Droy-Lefaix MT; Tarrade T; Koltai M
Cardiovasc Res; 1995 Nov; 30(5):781-7. PubMed ID: 8595627
[TBL] [Abstract][Full Text] [Related]
19. Levosimendan, a new positive inotropic drug, decreases myocardial infarct size via activation of K(ATP) channels.
Kersten JR; Montgomery MW; Pagel PS; Warltier DC
Anesth Analg; 2000 Jan; 90(1):5-11. PubMed ID: 10624967
[TBL] [Abstract][Full Text] [Related]
20. Mexiletine protects myocardium during acute ischemia by opening sarcolemmal K-ATP channel: studies in closed-chest acute ischemia model in rabbits.
Niwano S; Inuo K; Morohoshi Y; Nakayama S; Yuge M; Imaki R; Izumi T
J Cardiovasc Pharmacol; 2004 Dec; 44(6):639-44. PubMed ID: 15550781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
